The Campaign for Sustainable Rx Pricing, a coalition of hospitals, insurers, and businesses, has released a policy proposal that aims to increase drug-pricing transparency and promote competition. The coalition includes the Federation of American Hospitals, the American Hospital Association, the Blue Cross Blue Shield Association, Kaiser Permanente, and the AARP.
The proposal calls for the following reforms:
Not surprisingly, the pharmaceutical sector opposes any changes. An official with the Pharmaceutical Research and Manufacturers of America told the Washington Post that the coalition was a way for insurance companies to deflect scrutiny of their own role in drug pricing.